These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3521484)

  • 21. Paradox between the responses of Escherichia coli K1 to ampicillin and chloramphenicol in vitro and in vivo.
    Kim KS; Manocchio M; Anthony BF
    Antimicrob Agents Chemother; 1984 Nov; 26(5):689-93. PubMed ID: 6393867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with the use of cefotaxime in the treatment of bacterial meningitis.
    Cherubin CE; Eng RH
    Am J Med; 1986 Mar; 80(3):398-404. PubMed ID: 3513559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.
    Mylotte JM; Bates TR; Sergeant KA; Matson RE; Beam TR
    Antimicrob Agents Chemother; 1981 Jul; 20(1):81-7. PubMed ID: 7025751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin].
    Fourrier F; Chopin C; Lestavel P; Savage C
    Presse Med; 1986 Jun; 15(26):1240. PubMed ID: 2944094
    [No Abstract]   [Full Text] [Related]  

  • 25. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.
    Vanhoof R; Hubrechts JM; Roebben E; Nyssen HJ; Nulens E; Leger J; De Schepper N
    Infection; 1986; 14(6):294-8. PubMed ID: 3546145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Thauvin C; Lemeland JF; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1988 Jun; 32(6):919-21. PubMed ID: 3166360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Spontaneous infection of ascitic fluid due to Salmonella typhimurium in a cirrhotic patient undergoing selective intestinal decontamination with norfloxacin].
    Lecleire S; Di Fiore F; Hervé S; Goria O; Savoye G; Colin R; Lerebours E
    Presse Med; 2003 Mar; 32(12):550-2. PubMed ID: 12714922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefotaxime pharmacokinetics and treatment of meningitis in neonates.
    Jacobs RF; Kearns GL
    Infection; 1989; 17(5):338-42. PubMed ID: 2689352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy: a way to limit emergence of resistance?
    Michéa-Hamzehpour M; Pechère JC; Marchou B; Auckenthaler R
    Am J Med; 1986 Jun; 80(6B):138-42. PubMed ID: 3088999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.
    Scheld WM; Brodeur JP; Gratz JC; Foresman P; Rodeheaver G
    Antimicrob Agents Chemother; 1983 Nov; 24(5):682-8. PubMed ID: 6362552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.
    Barson WJ; Miller MA; Brady MT; Powell DA
    Pediatr Infect Dis; 1985; 4(4):362-8. PubMed ID: 3895175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic therapy of fulminant E. coli K1 sepsis in infant rabbits.
    Law BJ; Rettig PJ; Marks MI
    Pediatr Res; 1984 Apr; 18(4):314-7. PubMed ID: 6371694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Passage of pefloxacine into the synovial fluid].
    Prieur B; Di Menza C; Charlot J
    Presse Med; 1985 Nov; 14(39):2019-20. PubMed ID: 2933730
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
    Bayer AS; Hirano L; Yih J
    Antimicrob Agents Chemother; 1988 Feb; 32(2):231-5. PubMed ID: 3129985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group.
    Peltola H; Anttila M; Renkonen OV
    Lancet; 1989 Jun; 1(8650):1281-7. PubMed ID: 2566824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis.
    Scheld WM; Brown RS; Sande MA
    Antimicrob Agents Chemother; 1978 Jun; 13(6):899-904. PubMed ID: 354518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis.
    Scheld WM; Brodeur JP; Sande MA; Alliegro GM
    Antimicrob Agents Chemother; 1982 Oct; 22(4):652-6. PubMed ID: 6217785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefotaxime therapy of neonatal gram-negative bacillary meningitis.
    Naqvi SH; Maxwell MA; Dunkle LM
    Pediatr Infect Dis; 1985; 4(5):499-502. PubMed ID: 3900946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pefloxacine and severe eye infections].
    Massin-Cochereau I; Le Hoang P; Weiser M; Rousselie F
    Bull Soc Ophtalmol Fr; 1987; 87(6-7):735-6, 738. PubMed ID: 3499243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.